Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pacira Pharmaceuticals makes appointments

This article was originally published in Scrip

Executive Summary

Pacira Pharmaceuticals(US), an acute care speciality pharmaceutical company, has appointed Dr Gary Pace to its board of directors. Dr Pace is the founder and past chairman and CEO of QRx Pharma, and has also director and chairman positions for several speciality pharmaceutical companies. Pacira has also named Dr Bill Kirkpatrick, who has 30 years' medical regulatory and quality assurance experience, vice-president of compliance.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC031049

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel